D3Y-21232-55438
3 vaccinations
5 coded responses
19 check-ins
5 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 41-45
- ZIP prefix
- 921 / CA
- Registered
- 2021-04-27
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-23
Dose 1 — Moderna
-
2021-04-27
Registered in v-safe
-
2021-04-27
Dose 2 — Moderna
-
2021-04-28
Survey response — days 1–6 daily, dose 2MedDRA: Chills, Decreased appetite, Dehydration, Dizziness, Dysarthria, Dyspnoea, Feeling of body temperature change, Gait disturbance, Mental disorder, Mobility decreased, Muscle spasms, Neurological symptom — Feeling: Poor · Site: Pain, Swelling, Itching · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to work, Be unable to do your normal daily activitiesFree text: shivers, muscle spasms, mental / neurological degradation - inability to speak clearly. overall body cold feeling but burning up in certain areas. decreased flexibility and mobility. difficulty walking and using the bathroom. loss of appetite. feel dehydrated. light-headedness. muscle spasms.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-29
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fever · Chills, Headache, Fatigue or tiredness, Abdominal pain · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-04-30
Survey response — days 1–6 daily, dose 2MedDRA: Heart rate irregular — Feeling: Fair · Headache, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesFree text: irregular unsteady heartbeatMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-01
Health check-in — days 1–6 daily, dose 2Feeling: Good · Headache, Fatigue or tirednessAdult check-in
- 2021-05-03
- 2021-05-18
- 2021-05-25
- 2021-10-27
-
2021-10-28
Dose 3 — Moderna
- 2021-10-28
-
2021-10-29
Survey response — days 1–6 daily, dose 3MedDRA: Dyspnoea, Head discomfort, Insomnia, Tachyphrenia — Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Heavy head. Difficulty breathing nasally (nose). difficulty sleeping. overactive mind mental stateMedDRA releases: 2024-11 · check-in free text available
-
2021-10-30
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Swelling · Headache, Muscle or body aches, Fatigue or tiredness, DiarrheaAdult check-in
-
2021-10-31
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-11-01
Health check-in — days 1–6 daily, dose 3Feeling: Good · Fatigue or tiredness, Abdominal painAdult check-in
-
2021-11-03
Survey response — days 1–6 daily, dose 3MedDRA: Visual impairment, Vitreous floaters — Feeling: Fair · Headache, Fatigue or tirednessFree text: Eye floaters / visual problemsMedDRA releases: 2024-11 · check-in free text available
- 2021-11-04
- 2021-11-11
-
2021-11-18
Survey response — day 21, dose 3MedDRA: Blindness, Vitreous floaters — Feeling: FairFree text: loss of vision / eye floatersMedDRA releases: 2024-11 · check-in free text available
- 2021-11-25
- 2022-01-27
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-23 | Moderna | |
| 2 | 2021-04-27 | Moderna | |
| 3 | 2021-10-28 | Moderna | No |
Free text
Release 8 — days 1–6 daily, dose 2
Systemic reaction (other): shivers, muscle spasms, mental / neurological degradation - inability to speak clearly. overall body cold feeling but burning up in certain areas. decreased flexibility and mobility. difficulty walking and using the bathroom. loss of appetite. feel dehydrated. light-headedness. muscle spasms.
Systemic reaction (other): irregular unsteady heartbeat
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Heavy head. Difficulty breathing nasally (nose). difficulty sleeping. overactive mind mental state
Systemic reaction (other): Eye floaters / visual problems
Release 10 — day 21, dose 3
Symptoms: loss of vision / eye floaters
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Blindness | · | · | ✓ |
| SD | Vitreous floaters | · | · | ✓ |
| SRO | Chills | ✓ | ✓ | ✓ |
| SRO | Decreased appetite | ✓ | ✓ | ✓ |
| SRO | Dehydration | ✓ | ✓ | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
| SRO | Dysarthria | ✓ | ✓ | ✓ |
| SRO | Dyspnoea | ✓ | ✓ | ✓ |
| SRO | Feeling of body temperature change | ✓ | ✓ | ✓ |
| SRO | Gait disturbance | ✓ | ✓ | ✓ |
| SRO | Head discomfort | · | · | ✓ |
| SRO | Heart rate irregular | ✓ | ✓ | ✓ |
| SRO | Insomnia | · | · | ✓ |
| SRO | Mental disorder | ✓ | ✓ | ✓ |
| SRO | Mobility decreased | ✓ | ✓ | ✓ |
| SRO | Muscle spasms | ✓ | ✓ | ✓ |
| SRO | Neurological symptom | ✓ | ✓ | ✓ |
| SRO | Tachyphrenia | · | · | ✓ |
| SRO | Visual impairment | · | · | ✓ |
| SRO | Vitreous floaters | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release